Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease

Volume: 129, Pages: 383 - 388
Published: Sep 1, 2016
Abstract
The elevated cardiovascular morbidity and mortality in chronic kidney disease (CKD) is linked with endothelial dysfunction secondary to the pro-inflammatory and pro-oxidative state typical of this pathology. In consideration of the well-known pleiotropic effect of statins, we investigated the effect of cholesterol lowering treatment on endothelial dysfunction markers (MED), asymmetric dimethylarginine (ADMA), vascular cell (VCAM) and...
Paper Details
Title
Effect of cholesterol lowering treatment on plasma markers of endothelial dysfunction in chronic kidney disease
Published Date
Sep 1, 2016
Volume
129
Pages
383 - 388
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.